Safety of nifedipine in patients with hypertension: A meta-analysis

Hypertension

Volumn 30, Issue 1, 1997, Pages 7-14

  Stason, William B ^a,b,d   Schmid, Christopher H ^c   Niedzwiecki, Donna ^b   Whiting, Gregory W ^b   Luo, Donghan ^b   Ross, Susan D ^b   Chalmers, Thomas C ^b,c  

^a HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^b MetaWorks Inc   (United States)

^c TUFTS UNIVERSITY   (United States)

^d Tufts University ^*  (United States)

Author keywords

Meta analysis; Nifedipine; Safety

Indexed keywords

NIFEDIPINE;

ADULT; AGED; ANTIHYPERTENSIVE THERAPY; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; DRUG SAFETY; FEMALE; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; META ANALYSIS; PRIORITY JOURNAL;

EID: 0030788007     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.HYP.30.1.7     Document Type: Article

References (113)

1. Manolio TA, Cutler JA, Furberg CD, Psaty BM, Whelton PK, Applegate WB. Trends in pharmacologic management of hypertension in the United States. Arch Intern Med. 1995;155:829-837.
2. Psaty BM, Koepsell TD, Yanez ND. Temporal patterns of anti-hypertensive medication use among older adults, 1989-1992: an effect of major clinical trials on clinical practice? JAMA. 1995;273: 1436-1438.
3. Joint National Committee on Detection, Evaluation and Treatment of High Blood Pressure. The fifth report of the Joint National Committee on Detection, Evaluation and Treatment of High Blood Pressure (JNCV). Arch Intern Med. 1993;153:154-183.
4. Furberg CD, Psaty BM, Meyer JV. Nifedipine: dose-related increase in mortality in patients with coronary heart disease. Circulation. 1995;92:1326-1331.
5. Psaty BM, Heckbert SR, Koepsell TD, Siscovick DS, Raghunathan TE, Weiss NS, Rosendaal FR, Lemaitre RN, Smith NL, Wahl PW. The risk of myocardial infarction associated with anti-hypertensive drug therapies. JAMA. 1995;274:620-625.
6. Dahlof B, Hansson L, Lindholm LH, Schersten B, Wester PO, Ekbom T, Hedner T, de Faire V. STOP-Hypertension 2: a prospective intervention trial of newer versus older treatment alternatives in old patients with hypertension: Swedish Trial in Old Patients with Hypertension. Blood Pressure. 1993;2:136-141.
7. Amery A, Birkenhager W, Bulpitt CJ, Clement D, De Leeuw P, Dollery CT, Fagard R, Fletcher A, Forett F, Leonetti G. Syst-Eur: a multicentre trial on the treatment of isolated systolic hypertension in the elderly: objectives, protocol and organization. Aging. 1991;3:287-302.
8. The NORDIL Group. The Nordic Diltiazem Study (NORDIL): a prospective intervention trial of calcium antagonist therapy in hypertension. Blood Pressure. 1992;2:314-321.
9. Davis BR, Cutler JA, Gordon DJ, Furberg CD, Wright JT Jr, Cushman WC, Grimm RH, LaRosa J, Whelton PK, Perry HM, Alderman MH, Ford CE, Oparil S, Francis C, Proschan M, Pressel S, Black HR, Hawkins CM. Rationale and design for the Anti-hypertensive and Lipid Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). Am J Hypertens. 1996;9:342-360.
10. Sacks HS, Berrier J, Reitman D, Ancona-Berk VA, Chalmers TC. Meta-analysis of randomized controlled trials. N Engl J Med. 1987; 316:450-455.
11. Chalmers TC, Smith H Jr, Blackburn B, Silverman B, Schroeder B, Reitman D, Ambroz A. A method for assessing the quality of a randomized control trial. Clin Trials J. 1981;2:31-49.
12. Jadad AR, Moore RA, Carroll D, Jenkinson C, Reynolds JM, Gavaghan DJ, McQuay HJ. Assessing the quality of reports of randomised clinical trials: is blinding necessary? Control Clin Trials. 1996;17:1-2.
13. SAS Institute. SAS/STAT Users Guide. 4th ed. Cary, NC: SAS Institute; 1989:1071-1126.
14. DerSimonian R, Laird NM. Meta-analysis in clinical trials. Control Clin Trials. 1986;7:177-188.
15. Yusuf S, Peto R, Lewis J, Collins R, Sleight P. Beta blockade during and after myocardial infarction: an overview of randomized trials. Prog Cardiovasc Dis. 1985;27:335-371.
16. Hosmer DW, Lemeshow S. Applied Logistic Regression. New York, NY: John Wiley & Sons; 1989.
17. Albergati F, Paterno E, Venuti RP, Boeri D, Lombardo I, Semino S, Viviani GL, Adezati L. Comparison of the effects of carvedilol and nifedipine in patients with essential hypertension and non-insulin-dependent diabetes mellitus. J Cardiovasc Pharmacol. 1992;19(suppl 1):S86-S89.
18. Amabile G, Serradimigni A. Comparison of bisoprolol with nifedipine for treatment of essential hypertension in the elderly: comparative double-blind trial. Eur Heart J. 1987;8(suppl M):65-69.
19. Anderton JL, Vallance BD, Stanley NN, Crowe PF, Mittra B, Perks WH. Atenolol and sustained release nifedipine alone and in combination in hypertension: a randomised, double-blind, crossover study. Drugs. 1988;35(suppl 4):22-26.
20. Artigou JY, Benichou M, Berland J, Fressinaud P, Grollier G, Gueret P, Nguyen Cong Duc L. A randomized double-blind therapeutic trial of enalapril versus timed-release nifedipine in mild to moderate essential hypertension. Presse Med. 1990;19:13-16.
21. Attwood S, Bird R, Burch K, Casadei B, Coats A, Conway J, Dawes M, Ebbs D, Farmer A, Robinson J. Within-patient correlation between the antihypertensive effects of atenolol, lisinopril and nifedipine. J Hypertens. 1994;12:1053-1060.
22. Belz GG, Spies G. Controlled study on the treatment of hypertension with verapamil in retard form. Z Kardiol. 1985;74:453-459.
23. Bevan EG, Pringle SD, Waller PC, Herrick AL, Findlay JG, Murray GD, Carmichael HA, Reid JL, Weir RJ, Lorimer AR. Comparison of captopril, hydralazine and nifedipine as third drug in hypertensive patients. J Hum Hypertens. 1993;7:83-88.
24. Bochicchio T, Perez-Grovas HA, Carrizosa J, Herrera-Acosta J. Evaluation of the efficacy and safety of dilevalol in the treatment of essential arterial hypertension. Arch Inst Cardiol Mex. 1989;59: 181-186.
25. Bremner AD, Fell PJ, Hosie J, James IG, Saul PA, Taylor SH. Early side-effects of antihypertensive therapy: comparison of amlodipine and nifedipine retard. J Hum Hypertens. 1993;7:79-81.
26. Cacciapuoti F, Perrone N, Diaspro R, Galzerano D, Gentile S, Lapiello B. Slowing of mitral valve annular calcium in systemic hypertension by nifedipine and comparisons with enalapril and atenolol. Am J Cardiol. 1993;72:1038-1042.
27. Chaignon M, Lucsko M, Rapoud JP, Aubert P, Guedon J. Comparative effects of nifedipine and indapamide in the treatment of arterial hypertension. Arch Mal Coeur Vaiss, 1985;78(Spec No): 67-72.
28. Chamiec T, Zaleska T, Klos J, Pietrzykowska H, Bednarz B, Ceremuzynski L. Efficacy and tolerance of nifedipine retard vs acebutolol in patients with essential hypertension treated for 26 weeks. Mater Med Pol. 1989;21:49-52.
29. Chan JC, Cockram CS, Nicholls MG, Cheung CK, Swaminathan R. Comparison of enalapril and nifedipine in treating non-insulin dependent diabetes associated with hypertension: one year analysis. BMJ. 1992;305:981-985.
30. Chellingsworth MC, Kendall MJ, Wright AD, Singh BM, Pasi J. The effects of verapamil, diltiazem, nifedipine and propranolol on metabolic control in hypertensives with non-insulin dependent diabetes mellitus. J Hum Hypertens. 1989;3:35-39.
31. Clamp M, Holmes B, Wilcox R. Comparative trial of nifedipine retard and atenolol in the treatment of elderly patients with mild to moderate hypertension. J Hum Hypertens. 1990;4:557-563.
32. Corcoran JS, Perkins JE, Hoffbrand BI, Yudkin JS. Treating hypertension in non-insulin-dependent diabetes: a comparison of atenolol, nifedipine, and captopril combined with bendrofluazide. Diabet Med. 1987;4:164-168.
33. Daniels AR, Opie LH. Atenolol plus nifedipine for mild to moderate systemic hypertension after fixed doses of either agent alone. Am J Cardiol. 1986;57:965-970.
34. Decoulx M, Godon P, Pappo M, d'Allens H. Hypertension in the elderly: comparison of the efficacy and tolerability of labetalol and nifedipine. A multicenter, randomized, single-blind study. Ann Cardiol Angeiol (Paris). 1990;39:305-309.
35. de Divitiis O, Petitto M, Di Somma S, Fazio S, Galderisi M, Villari B, Liguori V, Santomauro M. Acebutolol and nifedipine in the treatment of arterial hypertension: efficacy and acceptability. Arzneimittelforschung. 1984;34:710-715.
36. de Divitiis O, Petitto M, Di Somma S, Galderisi M, Liguori V, Fazio S, Airoldi G. Therapeutic approach to arterial hypertension: comparison and combination of acebutolol with nifedipine and captopril. Cardiologia. 1985;30:469-475.
37. Ding YA, Law HW, Chou TC. Comparison of cilazapril and nifedipine retard on ambulatory blood pressure, metabolic, rheological and platelet function in hypertensive patients. J Hum Hypertens. 1994;8:137-143.
38. Douglas-Jones AP, Mitchell AD. Comparison of nifedipine (retard formulation) and mefruside in the treatment of mild to moderate hypertension - a prospective randomized double-blind crossover study in general practice. Postgrad Med J. 1984;60: 529-532.
39. Eber B, Brussee H, Rotman B, Kramer R, Klein W. Evaluation of the antihypertensive effect of lisinopril compared with nifedipine in patients with mild to severe essential hypertension. Angiology. 1992;43:482-489.
40. Edwards KG, Tweed JA, Saul PA, Wright FW. A comparative study of atenolol/nifedipine and atenolol/diuretic in hypertension. Pharmatherapeutica. 1986;4:637-641.
41. Egan BM, Fleissner MJ, Stepniakowski K, Neahring JM, Sagar KB, Ebert TJ. Improved baroreflex sensitivity in elderly hypertensives on lisinopril is not explained by blood pressure reduction alone. J Hypertens. 1993;11:1113-1120.
42. Fadayomi MO, Akinroye KK, Ajao RO, Awosika LA. Monotherapy with nifedipine for essential hypertension in adult blacks. J Cardiovasc Pharmacol. 1986;8:466-469.
43. Feig PU, Gibson L, MacCarthy EP, Pettis PP, Schwartz L. The efficacy and safety of once-daily nifedipine coat-core in the treatment of mild-to-moderate hypertension: Adalat CC Cooperative Study Group [published erratum appears in Clin Ther. 1994;16:125]. Clin Ther. 1993;15:963-975.
44. Fletcher AE, Battershy C, Adnitt P, Underwood N, Jurgensen HJ, Bulpitt CJ. Quality of life on antihypertensive therapy: a double-blind trial comparing quality of life on pinacidil and nifedipine in combination with a thiazide diuretic. European Pinacidil Study Group. J Cardiovasc Pharmacol. 1992;20:108-114.
45. Fletcher AE, Bulpitt CJ, Chase DM, Collins WC, Furberg CD, Goggin TK, Hewett AJ, Neiss AM. Quality of life with three antihypertensive treatments: cilazapril, atenolol, nifedipine. Hypertension. 1992; 19:499-507.
46. Frishman WH, Garofalo JL, Rothschild A, Rothschild M, Greenberg SM, Soberman J. Multicenter comparison of the nifedipine gastrointestinal therapeutic system and long-acting propranolol in patients with mild to moderate systemic hypertension receiving diuretics: a preliminary experience. Am J Med. 1987;83: 15-19.
47. Gavras I, Gavras H. Nifedipine in the treatment of essential hypertension. J Clin Pharmacol. 1985;25:429-432.
48. Gilchrist NL, Nicholls MG, Ewer TC, Livesey JH, Sainsbury R. A comparison of long acting nifedipine and enalapril in elderly hypertensives: a randomised, single-blind, cross-over study. J Hum Hypertens. 1988;2:33-39.
49. Guazzi MD, Cipolla C, Della Bella P, Fabbiocchi F, Montorsi P, Sganzerla P. Disparate unloading efficacy of the calcium channel blockers, verapamil and nifedipine, on the failing hypertensive left ventricle. Am Heart J. 1984;108:116-123.
50. Gueret P, Artigou JY, Benichou M, Berland J, Fressinaud P, Grollier G, Nguyen CD. Comparative efficacy and safety of enalapril and sustained-release nifedipine in patients with mild to moderate hypertension: the Enalapril vs Nifedipine French Study Group. Drugs. 1990;39(suppl 2):67-72.
51. Hallin L, Andren L, Hansson L. Controlled trial of nifedipine and bendroflumethiazide in hypertension. J Cardiovasc Pharmacol. 1983;5:1083-1085.
52. Halperin AK, Icenogle MV, Kapsner CO, Chick TW, Roehnert J, Murata GH. A comparison of the effects of nifedipine and verapamil on exercise performance in patients with mild to moderate hypertension. Am J Hypertens. 1993;6:1025-1032.
53. Hannedouche T, Fillastre JP, Mimran A, de Treglode D, Schardt F, Rosenthal T, Grossman F, Rocco S. Ketanserin versus nifedipine in the treatment of essential hypertension in patients over 50 years old: an international multicenter study. J Cardiovasc Pharmacol. 1987;10(suppl 3):S107-S112.
54. Harder S, Rietbrock S, Thurmann P. Antihypertensive efficacy of a slow release nifedipine tablet formulation given once daily in patients with mild to moderate hypertension: a placebo-controlled, double-blind parallel-group trial. Arzneimittelforschung. 1994;44:133-136.
55. Hart W, Clarke RJ. ACE inhibition versus calcium antagonism in the treatment of mild to moderate hypertension: a multicentre study. Ireland-Netherlands Lisinopril-Nifedipine Study Group. Postgrad Med J. 1993;69:450-455.
56. Henry M, Wehrlen M, Pelletier B, Capron MH. Spironolactone versus nifedipine in essential hypertension. Am J Cardiol. 1990;65: 36K-38K.
57. Hosie J, Nasar MA, Belgrave GP, Walters EG. A comparative study of long acting diltiazem (Tildiem LA) with sustained release nifedipine (nifedipine SR) and bendrofluazide in the treatment of mild to moderate hypertension. Acta Cardiol. 1994;49:251-265.
58. Houston MC, Olafsson L, Burger MC. Effects of nifedipine GITS and atenolol monotherapy on serum lipids, blood pressure, heart rate, and weight in mild to moderate hypertension. Angiology. 1991;42:681-690.
59. Jackson G, Thirkettle JL, Taylor DJ, Jackson PG, Brennand-Roper D, Vella R, Manivannan A, Flora HK, Gupta S, Chapman CM. A double-blind crossover trial of atenolol, enalapril and the fixed combination of atenolol and nifedipine in mild and moderate hypertension. Br J Clin Pract. 1993;47:66-70.
60. Jueng C, Halperin AK, Hashimoto F, Callender K. Nifedipine GITS and hydrochlorothiazide in essential hypertension. J Clin Hypertens. 1987;3:695-703.
61. Klein WW, Stuhlinger W, Mahr G. Cross-over comparison between captopril and nifedipine. Postgrad Med J. 1986;62(suppl 1): 108-110.
62. Landmark K, Dale J. Antihypertensive, haemodynamic and metabolic effects of nifedipine slow-release tablets in elderly patients. Acta Med Scand. 1985;218:389-396.
63. Lederballe Pedersen O, Christensen CK, Mikkelsen E, Ramsch KD. Relationship between the antihypertensive effect and steady-state plasma concentration of nifedipine given alone or in combination with a beta-adrenoceptor blocking agent. Eur J Clin Pharmacol. 1980;18:287-293.
64. Leon AS. Efficacy and safety of enalapril versus extended-release nifedipine for the treatment of mild-to-moderate essential hypertension: a multicenter 22-week study. Multicenter Cooperative Study Group [published erratum appears in Clin Ther. 1994; 16:125]. Clin Ther. 1993;15:1094-1107.
65. Letellier P, Overlack A, Agnes E, Desche P. Perindopril plus nifedipine versus perindopril plus hydrochlorothiazide in mild to severe hypertension: a double-blind multicentre study: the Multi-centre Study Group on Treatment Association with Perindopril. J Hum Hypertens. 1994;8:145-149.
66. MacCarthy EP, Pettis PP, Gibson L, Schwartz L, Feig PU. The safety and efficacy of once-daily nifedipine coat-core in combination with atenolol in hypertensive patients: Adalat CC Cooperative Study Group. Clin Ther. 1993; 15:976-987.
67. Maclean D, Mitchell ET, Coulson RR, Fitzsimons TJ, McDevitt DG. Atenolol-nifedipine combinations compared to atenolol alone in hypertension: efficacy and tolerability. Br J Clin Pharmacol. 1988;25:425-431.
68. Maclean D, Ramsay LE, Richardson PJ. Enalapril and nifedipine in the treatment of mild to moderate essential hypertension: a 6 month comparison. Br J Clin Pharmacol. 1990;30:203-211.
69. Martinez de la Iglesia J, de Diego Cabrera MS, Gonzalez Santos C, Iribarren Marin MA, Calderon de la Barca Gazquez JM, Perula Torres L. Comparison of chlorthalidone and sustained-action nifedipine in the treatment of mild to moderate arterial hypertension. Aten Primaria. 1990;7:258, 260, 262-264.
70. Midtbo K, Hals O, van der Meer J. Verapamil compared with nifedipine in the treatment of essential hypertension. J Cardiovasc Pharmacol. 1982;4(suppl 3):S363-S368.
71. Morlin C, Baglivo H, Boeijinga JK, Breckenridge AM, Clement D, Johnston GD, Klein W, Kramer R, Luccioni R, Meurer KA. Comparative trial of lisinopril and nifedipine in mild to severe essential hypertension. J Cardiovasc Pharmacol. 1987;9(suppl 3):S49-S52.
72. Murphy MB, Scriven AJ, Dollery CT. Efficacy of nifedipine as a step 3 antihypertensive drug. Hypertension. 1983;5(suppl II):II-118-II-121.
73. Myers MG, Leenen FH, Burns R, Frankel D. Nifedipine tablet vs. hydralazine in patients with persisting hypertension who receive combined diuretic and beta-blocker therapy. Clin Pharmacol Ther. 1986;39:409-413.
74. Nifedipine-Atenolol Study Review Committee. Nifedipine and atenolol singly and combined for treatment of essential hypertension: comparative multicentre study in general practice in the United Kingdom. Br Med J. 1988;296:468-473.
75. O'Donnell MJ, Rowe BR, Lawson N, Horton A, Gyde OH, Barnett AH. Comparison of the effects of an angiotensin converting enzyme inhibitor and a calcium antagonist in hypertensive, macroproteinuric diabetic patients: a randomised double-blind study. J Hum Hypertens. 1993;7:333-339.
76. Ohman KP, Weiner L, von Schenck H, Karlberg BE. Antihypertensive and metabolic effects of nifedipine and labetalol alone and in combination in primary hypertension. Eur J Clin Pharmacol. 1985;29:149-154.
77. Opsahl JA, Halstenson CE, Abraham PA. Antihypertensive and humoral effects of nifedipine in essential hypertension uncontrolled by hydrochlorothiazide alone. Am J Hypertens. 1989;2: 828-833.
78. Os I, Bratland B, Dahlof B, Gisholt K, Syvertsen JO, Tretli S. Lisinopril or nifedipine in essential hypertension? A Norwegian multicenter study on efficacy, tolerability and quality of life in 828 patients [published erratum appears in J Hypertens. 1992;10: following H9]. J Hypertens. 1991;9:1097-1104.
79. Pacheco JP, Fan F, Wright RA, Corkadel LK, Horwitz LD, Reeves RL. Monotherapy of mild hypertension with nifedipine. Am J Med. 1986;81:20-24.
80. Palmer A, Fletcher A, Hamilton G, Muriss S, Bulpitt C. A comparison of verapamil and nifedipine on quality of life. Br J Clin Pharmacol. 1990;30:365-370.
81. Palmer A, Fletcher A, Hamilton G, Muriss S, Bulpitt C. A comparison of the effects of verapamil and nifedipine on the quality of life. Wien Med Wochenschr. 1991;141:424-428.
82. Poulter NR, Sanderson JE, Thompson AV, Sever PS, Chang CL. Comparison of nifedipine and propranolol as second line agent for hypertension in black Kenyans. BMJ. 1993;306:621-622.
83. Predel HG, Kramer HJ. Lisinopril versus slow release nifedipine in patients with essential hypertension: a multicentre study. J Hum Hypertens. 1994;8:777-780.
84. Ramsay LE, Parnell L, Waller PC. Comparison of nifedipine, prazosin and hydralazine added to treatment of hypertensive patients uncontrolled by thiazide diuretic plus beta-blocker. Postgrad Med J. 1987;63:99-103.
85. Richardson PJ, Meany B, Breckenridge AM, Grimmer SF, Johnston GD, Kondowe G. Lisinopril in essential hypertension: a six month comparative study with nifedipine. J Hum Hypertens. 1987;1:175-179.
86. Richardson PJ, Meany TB, Johnston GD, Kondowe G, Grimmer SF, Breckenridge AM. Comparative efficacy of lisinopril and nifedipine retard in essential hypertension: a double-blind, placebo-controlled trial. J Cardiovasc Pharmacol. 1987;10(suppl 10): S96-S98.
87. Roberts DH, Tsao Y, Linge K, McLoughlin GA, Breckenridge A. Double-blind comparison of captopril with nifedipine in hypertension complicated by intermittent claudication. Angiology. 1992; 43:748-756.
88. Rogstad B. A comparison of lisinopril and nifedipine in the treatment of mild to moderate hypertension: a multicentre study. Eur J Clin Pharmacol. 1994;46:487-489.
89. Salvetti A, Innocenti PF, Iardella M, Pambianco F, Saba GC, Rossetti M, Botta GF. Captopril and nifedipine interactions in the treatment of essential hypertensives: a crossover study. J Hypertens Suppl. 1987;5:S139-S142.
90. Schulte KL, Meyer-Sabellek WA, Haertenberger A, Thiede HM, Roecker L, Distler A, Gotzen R. Antihypertensive and metabolic effects of diltiazem and nifedipine. Hypertension. 1986;8:859-865.
91. Senior R, Imbs JL, Bory M, Amabile G, Denis B, Zannad F, DeLuca N, Marchegiano R, Lahiri A, Raftery EB. Indapamide reduces hypertensive left ventricular hypertrophy: an international multicenter study. J Cardiovasc Pharmacol. 1993;22(suppl 6):S106-S110.
92. Serradimigni A, Perchicot E, Griener L, Kerihuel JC, Benichou M. Antihypertensive effect of a new form of nifedipine compared to a beta-blocker during chronic administration. Arch Mal Coeur Vaiss. 1985;78(Spec No):73-81.
93. Shamiss A, Meisel S, Nussinovitch N, Rosenthal T. Verapamil versus nifedipine in slow-release preparations for the treatment of mild to moderate hypertension. J Hum Hypertens. 1990;4:465-468.
94. Singer DR, Markandu ND, Shore AC, MacGregor GA. Nifedipine and acebutolol in combination for the treatment of moderate to severe essential hypertension. J Hum Hypertens. 1987;1:31-37.
95. Skinner MH, Futterman A, Morrissette D, Thompson LW, Hoffman BB, Blaschke TF. Atenolol compared with nifedipine: effect on cognitive function and mood in elderly hypertensive patients. Ann Intern Med. 1992;116:615-623.
96. Skoularigis J, Eitzman L, Davis J, Strugo V, Sareli P. Nifedipine versus captopril in the management of moderate hypertension in black patients. Am J Hypertens. 1994;7:440-447.
97. Smith DH, Neutel JM, Jankelow D, Pretorius JJ, Myburgh DP. A comparative study of atenolol, nifedipine and their combination in the treatment of hypertension. S Afr Med J. 1991;79:12-15.
98. Steiner A, Hany S, Battig B, Jenni R, Troesch M, Willimann P, Graf A, Leutenegger F, Angehm V, Beck G. Betaxolol versus nifedipine in the treatment of essential hypertension. Schweiz Rundsch Med Prax. 1988;77:1101-1103.
99. Steiner G, Pauly NC. Comparison of the efficacy and safety of trandolapril and nifedipine SR in mild-to-moderate hypertension: Investigator Study Group. J Cardiovasc Pharmacol. 1994;23(suppl 4):S81-S85.
100. Stumpe KO, Feldhaus P, Haerlin R. Antihypertensive effect and tolerance to urapidil: comparison with nifedipine in a multicenter double-blind study. Fortschr Med. 1989;107:54-57.
101. Sullivan FM, Murray TS, Gaw N, Langan JJ, Adams-Strump BJ. Is nifedipine a suitable first-line treatment for essential hypertension in general practice? Eur Heart J. 1987;8(suppl K):21-25.
102. Svetkey LP, Weinberger MH, Gavras H, Gavras I, Brown TS, Deterding J, Klotman PE. Double-blind, placebo-controlled trial of twice-daily nifedipine as a step-2 agent in mild essential hypertension. J Clin Hypertens. 1987;3:579-588.
103. Testa MA, Hollenberg NK, Anderson RB, Williams GH. Assessment of quality of life by patient and spouse during antihypertensive therapy with atenolol and nifedipine gastrointestinal therapeutic system. Am J Hypertens. 1991;4:363-373.
104. Van Hoof R, Desager JP, Harvengt C, Fagard R, Lijnen P, Peerenboom P, Staessen J, Thijs L, Van Mieghem W, Amery A. Comparison of the effect of celiprolol and nifedipine on blood pressure and plasma lipids. J Cardiovasc Pharmacol. 1992;20: 268-273.
105. Waller PC, Solomon SA, Ramsay LE. Comparison of ketanserin and slow-release nifedipine added to the treatment of hypertensive patients uncontrolled by a thiazide diuretic plus beta-adrenoceptor blocker. Br J Clin Pharmacol. 1987;24:591-597.
106. Walley T, Tsao Y, Scott A, Mackay E, Vandenburg M, Breckenridge A. Effects of dilevalol (R,R-labetalol) compared with nifedipine on heart rate, blood pressure and muscle blood flow at rest and on exercise in hypertensive patients. Br J Clin Pharmacol. 1993;35:623-628.
107. Weir MR, Lavin PT. Comparison of the efficacy and tolerability of Prinivil and Procardia XL in black and white hypertensive patients. Clin Ther. 1992;14:730-739.
108. Wing LM, Chalmers JP, West MJ, Bune AJ. Slow-release nifedipine as a single or additional agent in the treatment of essential hypertension: a placebo-controlled crossover study. Clin Exp Hypertens A. 1985;7:1173-1185.
109. Witchitz S, Serradimigni A, Lisinopril versus slow-release nifedipine in the treatment of mild to moderate hypertension: a multi-centre study. The Cooperative Study Group. J Hum Hypertens. 1989;3(suppl 1):29-33.
110. Woo KS, Pun CO. Long-acting nifedipine versus metoprolol as monotherapy for essential hypertension: a randomized, controlled crossover study. West J Med. 1990;152:149-152.
111. Zachariah PK, Schwartz GL, Sheps SG, Schirger A, Carlson CA, Moore AG. Antihypertensive effects of a new sustained-release formulation of nifedipine. J Clin Pharmacol. 1990;30:1012-1019.
112. Zucchelli P, Zuccala A, Borghi M, Fusaroli M, Sasdelfi M, Stallone C, Sanna G, Gaggi R. Long-term comparison between captopril and nifedipine in the progression of renal insufficiency. Kidney Int. 1992;42:452-458.
113. Zusman R, Christensen D, Federman E, Kochar MS, McCarron D, Porush JG, Spitalewitz S. Comparison of nifedipine and propranolol used in combination with diuretics for the treatment of hypertension. Am J Med. 1987;82:37-41.